Stiff-person syndrome
Drug research and approvals for stiff-person syndrome: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 3 studies of stiff-person syndrome are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 1 open orphan designations naming it.
- Recruiting worldwide: 3
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- VYVGART (Hytrulo) in Patients With Stiff Person Syndrome (SPS)NCT07860021 · Phase 2 / Phase 3 · Thomas Jefferson University · starts Sep 30, 2026
- A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101NCT07403188 · Not reported · Kyverna Therapeutics · starts Nov 24, 2025
- Biomarkers in Autoimmune Disease of Nervous SystemNCT06502015 · Not reported · Tongji Hospital · starts Jul 31, 2024
Approved 1
- DiazepamGABA-A receptor; anion channel positive allosteric modulator
Phase 3 1
- Human immunoglobulin gReplacement therapy, immunomodulatory effects
Phase 2 4
- RituximabB-lymphocyte antigen CD20 binding agent
- CytarabineDNA inhibitor
- PrednisoneGlucocorticoid receptor agonist
- CarmustineGlutathione reductase inhibitor
Phase 1 or earlier 3
- 2-mercaptoethanesulfonic acid
- FilgrastimGranulocyte colony stimulating factor receptor agonist
- CyclophosphamideDNA inhibitor
| Date | Drug | Sponsor | Status |
|---|---|---|---|
| Jul 31, 2008 | Intravenous immune globulin (human) 10%Treatment of stiff-person syndrome | Octapharma USA, Inc. | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA